Neuraxis Inc. (NRXS)
NYSE · Healthcare
Neuraxis Inc. EBITDA 2022–2025
Neuraxis Inc. annual/quarterly ebitda history and growth rate from 2022 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Neuraxis Inc. ebitda for the quarter ending March 31, 2026 was -1.7 M, a 24.66% decrease year-over-year.
- Neuraxis Inc. ebitda for the twelve months ending March 31, 2026 was -7.8 M, a 19.19% increase year-over-year.
- Neuraxis Inc. annual ebitda for 2025 was -7.8 M, a 9.15% increase from 2024.
- Neuraxis Inc. annual ebitda for 2024 was -7.1 M, a 7.48% increase from 2023.
- Neuraxis Inc. annual ebitda for 2023 was -6.6 M, a 98.61% increase from 2022.
- Neuraxis Inc. annual ebitda for 2022 was -3.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Neuraxis Inc. EBITDA — FAQ
Neuraxis Inc. (NRXS) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRXS's ebitda history?
The chart and table above show Neuraxis Inc.'s ebitda by year and by quarter, including the growth rate.